Squarepoint
ALIM

Squarepoint’s Alimera Sciences ALIM Stock Holding History

Squarepoint’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,687
Closed -$31K – 1312
2016
Q2 		$31K Buy
+1,687
New +$44.9K ﹤0.01% 1049

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Scale Management Foster City, California $359M AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Squarepoint's ALIM Position: Q3 2016 in Review

Squarepoint sold out of Alimera Sciences (ALIM) in Q3 2016, closing a stake of 1,687 shares — an estimated $31K sold.

Squarepoint first reported a position in ALIM in Q2 2016 and held it in 1 quarter. The position peaked at $31K in Q2 2016. 54 funds tracked by Wall St. Rank hold ALIM as of Q3 2016.

  • Squarepoint reported no remaining Alimera Sciences position as of Q3 2016 after selling out during the quarter.
  • Squarepoint sold 1,687 Alimera Sciences shares in Q3 2016, an estimated $31K.
  • Squarepoint first reported a position in Alimera Sciences in Q2 2016 and held it in 1 quarter.
  • Squarepoint's Alimera Sciences position peaked at $31K in Q2 2016.
  • 54 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2016.

Based on Squarepoint's 13F filing for Q3 2016, filed 15 Nov 2016.